Iomeprol Injectable Solution 350 mg/mL and 400 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injectable Solution

Available Strengths: 350 mg/mL and 400 mg/mL

Reference Brands: Iomeron(US & EU)

Category: Contrast Agent

Iomeprol is a contrast agent that enhances tissue and vascular visibility during imaging by increasing radiopacity. It supports accurate diagnosis, improves visualization of blood vessels and organs, and facilitates precise imaging in angiography, CT scans, and diagnostic procedures. Benefits include high-quality imaging, safety, and rapid excretion, supporting effective healthcare worldwide.

Product Description: Iomeprol injectable solution, marketed as Iomeron, is approved in the US by the FDA and in the EU via EMA for contrast-enhanced imaging procedures including CT angiography and vascular imaging. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality information to ensure safety and effectiveness, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports timely approval, safe administration, and worldwide availability, supporting high-quality diagnostic imaging globally.